Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOIIW) Acquisitions (2021 - 2023)

Oncology Institute posted quarterly Acquisitions of $156000.0 for Q4 2023, down 66.81% year-on-year from $470000.0 in Q4 2022, and down 66.81% on a QoQ basis from $470000.0 in Q4 2022.

Oncology Institute (TOIIW) has 3 years of Acquisitions data on file, last reported at $156000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Acquisitions fell 66.81% year-over-year to $156000.0; the trailing twelve-month figure through Dec 2024 stood at $156000.0 (up 183.42% YoY), and the FY2023 full-year result was $4.5 million, down 48.05% from the prior year.
  • Acquisitions for Q4 2023 stood at $156000.0, down from $470000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $8.9 million in Q2 2022 and bottomed at -$813000.0 in Q3 2022.
  • The 3-year median for Acquisitions is $648500.0 (2021), against an average of $3.0 million.
  • The widest annual swing landed in 2022, when Acquisitions sank 94.32%; it then tumbled 66.81% in 2023.
  • A 3-year view of Acquisitions shows it stood at $8.3 million in 2021, then tumbled by 94.32% to $470000.0 in 2022, then sank by 66.81% to $156000.0 in 2023.
  • The last three Acquisitions figures came in at $156000.0 (Q4 2023), $470000.0 (Q4 2022), and -$813000.0 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 121.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 33.92 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 28.74 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 4.86 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -3.49 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 20.61 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Oncology Institute - - 139.16 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 156,000.00
Dec 31, 2022 470,000.00
Sep 30, 2022 -813,000.00
Jun 30, 2022 8.92 Mn
Dec 31, 2021 8.28 Mn
Mar 31, 2021 827,000.00